These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 25990370

  • 1. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
    Gafni RI, Guthrie LC, Kelly MH, Brillante BA, Christie CM, Reynolds JC, Yovetich NA, James R, Collins MT.
    J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
    [Abstract] [Full Text] [Related]

  • 2. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.
    Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4214-20. PubMed ID: 12970289
    [Abstract] [Full Text] [Related]

  • 3. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.
    Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT.
    J Bone Miner Res; 2012 Aug; 27(8):1811-20. PubMed ID: 22492501
    [Abstract] [Full Text] [Related]

  • 4. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
    Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
    [Abstract] [Full Text] [Related]

  • 5. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD.
    Osteoporos Int; 2000 Feb; 11(5):434-42. PubMed ID: 10912846
    [Abstract] [Full Text] [Related]

  • 6. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis.
    Finkelstein JS, Arnold AL.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1214-9. PubMed ID: 10199756
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ, Chesnut CH, Mallinak NJ.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
    Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
    Tangpricha V, Luo M, Fernández-Estívariz C, Gu LH, Bazargan N, Klapproth JM, Sitaraman SV, Galloway JR, Leader LM, Ziegler TR.
    JPEN J Parenter Enteral Nutr; 2006 Jun; 30(6):480-6. PubMed ID: 17047171
    [Abstract] [Full Text] [Related]

  • 10. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib.
    Tollin SR, Perlmutter S, Aloia JF.
    J Bone Miner Res; 2000 Jul; 15(7):1412-6. PubMed ID: 10893692
    [Abstract] [Full Text] [Related]

  • 11. Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study.
    Matsumoto T, Shiraki M, Hagino H, Iinuma H, Nakamura T.
    Osteoporos Int; 2006 Oct; 17(10):1532-8. PubMed ID: 16767525
    [Abstract] [Full Text] [Related]

  • 12. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
    Winer KK, Yanovski JA, Cutler GB.
    JAMA; 1996 Aug 28; 276(8):631-6. PubMed ID: 8773636
    [Abstract] [Full Text] [Related]

  • 13. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.
    Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L, Hypoparathyroid Study Group.
    J Bone Miner Res; 2011 Oct 28; 26(10):2358-70. PubMed ID: 21773992
    [Abstract] [Full Text] [Related]

  • 14. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA, Goswami R, Singh N, Gupta N, Seith A.
    Clin Endocrinol (Oxf); 2006 Apr 28; 64(4):405-9. PubMed ID: 16584512
    [Abstract] [Full Text] [Related]

  • 15. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.
    Angelopoulos NG, Goula A, Tolis G.
    Exp Clin Endocrinol Diabetes; 2007 Jan 28; 115(1):50-4. PubMed ID: 17286236
    [Abstract] [Full Text] [Related]

  • 16. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR, Cusano NE, Fan WW, Delgado Y, Zhang C, Costa AG, Cremers S, Dworakowski E, Bilezikian JP.
    J Clin Endocrinol Metab; 2016 Jul 28; 101(7):2742-50. PubMed ID: 27144931
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H.
    Clin Ther; 2014 May 28; 36(5):722-36. PubMed ID: 24802860
    [Abstract] [Full Text] [Related]

  • 18. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
    Finkelstein JS, Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM.
    JAMA; 2014 May 28; 280(12):1067-73. PubMed ID: 9757854
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M, Díaz G, Nicolau J, Fernández C, Rueda S, Halperin I.
    Eur J Endocrinol; 2008 Nov 28; 159(5):653-7. PubMed ID: 18703565
    [Abstract] [Full Text] [Related]

  • 20. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR, Sliney J, McMahon DJ, Silverberg SJ, Bilezikian JP.
    Osteoporos Int; 2010 Nov 28; 21(11):1927-34. PubMed ID: 20094706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.